What Are the Most Common Reasons UK Patients Start Looking into Medical Cannabis?

In recent years, more people in the UK have been exploring medical cannabis as a treatment option for various health conditions. But what exactly is medical cannabis, and why are patients considering it? This post will explain the basics in plain English, clarify how the UK regulates medical cannabis, and outline the practical differences between NHS (National Health Service) and private clinic pathways — especially concerning common reasons for seeking it. If you’ve heard terms like “unlicensed medicines” or wonder about specialist consultations, this guide will help you understand what’s going on.
What Is Medical Cannabis?
Medical cannabis refers to cannabis-based products specifically used for medical treatment, containing carefully measured amounts of cannabinoids. Cannabinoids are the active chemical compounds found in the cannabis plant. The two most well-known cannabinoids are:
THC (Tetrahydrocannabinol): The compound that produces the “high” sensation. CBD (Cannabidiol): Does not cause intoxication and is often used for symptom management.
Medical cannabis products may include oils, tablets, sprays, or dried flower, but in the UK, medical cannabis is only available on prescription under very specific circumstances.
UK Legality and How Medical Cannabis Is Regulated
Medical cannabis was legalised for prescription use in the UK from November 2018. However, the rules are strict:
Only specialist doctors (consultants) can prescribe it. GPs cannot prescribe medical cannabis directly. The licensed conditions for prescribing are limited, and many uses are considered off-label or involve unlicensed medicines (more on this below). Prescribing medical cannabis on the NHS is rare and tightly controlled.
Here is the bit people miss: Just because medical cannabis is legal doesn’t mean it’s easy to get. The law requires prescribers to be confident that no other licensed medicine will work better and that the benefits outweigh risks for the patient.
Common Reasons UK Patients Start Looking Into Medical Cannabis
Many patients consider medical cannabis when standard treatments have not helped or caused intolerable side effects. Here are the most frequent reasons:
1. Chronic Pain Management
Chronic pain (pain lasting for more than 3 months) is a major reason patients explore medical cannabis for pain. Conditions include:
Neuropathic pain (nerve damage-related pain) Fibromyalgia Arthritis pain Multiple sclerosis (MS) spasticity and pain
Patients often report that conventional painkillers (opioids, NSAIDs) either don’t provide relief or cause problematic side effects. Medical cannabis may offer an alternative by helping reduce pain levels and improving quality of life.
2. Epilepsy and Seizure Disorders
Certain rare, severe epilepsy syndromes respond to cannabinoid treatments. Epidiolex (a CBD-based medicinal product) is licensed for some childhood epilepsies. Due to its complexity, this requires specialist evaluation and ongoing monitoring.
3. Multiple Sclerosis Symptoms
MS patients seek relief from muscle stiffness and spasms. Sativex (nabiximols) is a licensed mouth spray available for MS-related spasticity but is only sometimes available on the NHS due to cost and local funding decisions.
4. Chemotherapy-Related Nausea and Appetite Loss
Some patients look into cannabis-based medicines for symptom control during cancer treatment, especially when conventional anti-sickness drugs haven’t worked.
5. Anxiety, PTSD, and Mental Health Symptoms (Less Common and Controversial)
There lifeloving.co.uk https://lifeloving.co.uk/a-plain-english-guide-to-medical-cannabis-for-people-managing-chronic-conditions-in-the-uk/ is ongoing debate about cannabis use for mental health. Some patients explore medical cannabis to manage anxiety or PTSD symptoms, though evidence is limited and prescribing is cautious.
Specialist Consultation Reasons: NHS vs Private Clinics
Because only specialists can prescribe medical cannabis, the pathway starts with a referral — but the experience differs depending on whether you use the NHS or go private.
NHS Pathway Your GP refers you to a relevant NHS specialist (e.g., neurologist, pain consultant). The specialist assesses you and considers all standard treatment options. If suitable and evidence supports it, the specialist may consider medical cannabis (either licensed products like Sativex or unlicensed cannabis-based medicines). If prescribed, your medicine is managed by the specialist and sometimes your GP.
The NHS reality is that medical cannabis prescriptions are very rare. Many patients wait months or years for assessment, and some specialists are reluctant to prescribe due to lack of robust evidence or funding constraints.
Private Clinic Pathway You book a consultation with a private medical cannabis specialist (usually a consultant). The specialist reviews your medical history, diagnoses, and prior treatments. If appropriate, they may prescribe medical cannabis products that are unlicensed but widely used internationally. You pay for consultations and prescriptions out of pocket.
There is often less waiting time to see a private specialist, but this comes at a cost. However, private clinics may offer more flexible treatment options within the constraints of current UK law.
What Are Unlicensed Medicines and Why Does Specialist Judgement Matter?
Unlicensed medicines are medications that have not been formally approved for use by the UK medicines regulator (MHRA) for a specific indication or product form but can be prescribed if a clinician judges them necessary. Medical cannabis products fall heavily into this category because most formulations do not have a formal UK license.

Here is the bit people miss:
Unlicensed prescribing requires the specialist to take full responsibility for the decision, weighing benefits, risks, and available evidence. GPs are generally expected to continue prescriptions only after a specialist initiates treatment and passes on clinical details. This legal framework supports cautious, personalised treatment but makes it harder for general access. Chronic Condition Options in the UK: Is Medical Cannabis Suitable for Me? Condition Medical Cannabis Status on NHS Private Clinic Approach Notes Chronic Neuropathic Pain Rarely prescribed; limited evidence May be prescribed using unlicensed cannabis oils or flowers Often a last resort after standard pain management Multiple Sclerosis Spasticity Sativex approved; access varies by region Same; private supply possible Considered a licensed cannabis-based medicine Severe Epilepsy Syndromes Epidiolex available on NHS for certain cases Private options similar; specialist-led Strict monitoring required Cancer-related Symptoms Occasionally prescribed for nausea Often offered privately Usually adjunct to standard therapies Mental Health Conditions Not standard; prescribed with caution Private prescriptions more common but controversial Requires careful specialist assessment Summary and Practical Advice
If you’re considering medical cannabis in the UK, keep in mind:
Start with your GP: Get an honest conversation about your symptoms and treatments, and ask about specialist referrals. Understand the evidence: Medical cannabis is not a cure-all. It’s mainly considered when other options fail. Know the pathways: NHS access is limited and slow; private clinics offer faster access but involve costs. Expect specialist judgement: Prescribers have duties to assess safety and suitability thoroughly. Research carefully: Beware of overstated claims and unregulated products.
Medical cannabis continues to be an area of active research and evolving practice. For patients with chronic pain, neurological conditions, or chemotherapy symptoms who haven’t found relief, it may be worth discussing this option with a specialist to understand if it could be appropriate.

Remember, your healthcare decisions should always be guided by qualified professionals, not self-diagnosis or unverified information.